跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 88 条关于
“ADAM17”
全部
88
临床试验
40
药物
24
机构
11
资讯
13
10个月前
Novel Monoclonal Antibody F9H4 Prevents CD16a/b Shedding to Enhance NK Cell-Mediated Cancer Immunotherapy
去年
TREM2 Emerges as Dual Regulator of Lipid Metabolism and Immune Response in MASH
去年
Resiniferatoxin Receives FDA Breakthrough Therapy Designation for Osteoarthritis Pain
去年
Adams Clinical Expands into Inpatient Psychiatry and Schizophrenia Trials via InSite Partnership
去年
ADAR1 Gene Identified as Key Driver of Lenalidomide Resistance in Multiple Myeloma
4个月前
Hedge Fund ADAR1 Capital Invests $37 Million in Crinetics Pharmaceuticals Following Palsonify Launch
8个月前
ADAMA and BASF Partner to Commercialize Novel Fungicide Gilboa for European Cereal Disease Management
去年
Novel ADAR1 Inhibitor Rebecsinib Shows Promise in Halting Cancer Progression Through Space-Based Research
去年
Redwire Secures Contract with Aspera Biomedicines for Space-Based Cancer Research Using ADAR1 Inhibitor Rebecsinib
上个月
First-in-Class ADAR1 Inhibitor Rebecsinib Enters Phase 1 Trial for AML and Myelofibrosis at UC San Diego
第 1 页,共 2 页
上一页
下一页